Minimizing the Burden of Influenza: New and Emerging Strategies

Release Date: October 31, 2020 
Last Reviewed: October 26, 2020
Expiration Date: October 31, 2021
Time to Complete Activity: 1.0 hour

*This activity expired for credit on October 31, 2021 and is no longer available for credit

Faculty and Steering Committee

Ruth M. Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP
Professor, Division of Infectious Diseases
Department of Medicine 
University of Louisville School of Medicine
Louisville, KY

Laura Gunder McClary, DHSc, PA-C
Professor
Rocky Mountain University of Health Professions
Provo, UT

Charles Vega, MD
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Executive Director
UC Irvine Program in Medical Education for the Latino Community
Santa Ana, CA
This activity is provided by Paradigm Medical Communications, LLC.      

Disclosure of Commercial Support
This activity is supported by an educational grant from Genentech, a member of the Roche Group.    

Target Audience
This activity has been designed to address the educational needs of nurse practitioners and PAs.

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Identify appropriate candidates for antiviral therapy based on risk of influenza-related complications, in accordance with current guideline recommendations 
  • Determine the need for influenza treatment based on signs and symptoms and on accurate interpretation of appropriate diagnostic tests, when necessary
  • Develop individualized antiviral treatment plans for patients with, or at risk of, influenza that accord with the latest evidence 

Agenda

  • Introduction
  • Case Study: Does This Patient Have Influenza?
  • Case Studies: When Is Antiviral Therapy Appropriate? Which One Should I Use?


PA Continuing Education
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  This activity is accredited from 10/31/20 - 10/31/21 AAPA reference number: CME-200765.

Nurse Practitioner Continuing Education
This activity is approved for 1.0 contact hour of continuing education by the American Association of Nurse Practitioners. Activity ID 20104577. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Instructions for Participation 
To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the preactivity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com or (845) 398-5949.

There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

Faculty and Steering Committee

Ruth M. Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP
Consulting Fees: Sanofi Pasteur
Speakers Bureau: Pfizer Inc; Sanofi Pasteur
Grant/Research Support: Dynavax Technologies; Pfizer Inc; Sanofi Pasteur

Laura Gunder McClary, DHSc, PA-C
Dr Gunder McClary has no relevant financial interests regarding the content of this activity.

Charles Vega, MD
Dr Vega has no relevant financial interests regarding the content of this activity.

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC. 

Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com. 

© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.